With a large portfolio of world’s most prominent and innovative suppliers, we are ready to help you selecting the right products for your Coronavirus research. Explore the research solutions of a selection of our suppliers (an overview in alphabetical order).
Absolute Antibody
Absolute Antibody offers a variety of recombinant coronavirus reagents to support COVID-19 research and diagnostics, including anti-SARS-CoV-2 spike glycoprotein and nucleoprotein
antibodies, anti-human immunoglobulin antibodies and ACE2 Fc fusion proteins.
Anti-SARS-CoV-2 Spike Glycoprotein Antibody (Clone CR3022)
| Article number (other formats/sizes/species available) | Description |
| Ab01680-1.6 | Anti-COVID-19 & SARS-CoV S glycoprotein [Clone CR3022] |
Anti-SARS-CoV-2 Nucleoprotein Antibodies
Absolute Antibody offers two anti-SARS-CoV-2 nucleoprotein (nucleocapsid) antibodies for COVID-19 research and diagnostics, both available in engineered formats such as human IgG1, IgG3, IgM and IgA; antibody fragments; and species such as rabbit and mouse.
| Article number (other formats/sizes/species available) | Description |
| Ab01690-1.6 | Anti-Covid-19 & SARS-CoV Nucleoprotein [Clone CR3018 (03-018)] |
| Ab01691-1.6 | Anti-Covid-19 & SARS-CoV Nucleoprotein [Clone CR3009 (03-009)] |
Anti-SARS-CoV-2 Spike Protein & RBD Antibodies and Nanobodies
The range includes various antibodies against the receptor binding domain (RBD) of SARS-CoV-2. Absolute Antibody also offers two neutralizing anti-spike and RBD antibodies (CV1 and CV30) obtained from a SARS-CoV-2 patient, recombinantly produced and engineered into new formats.
| Article number (more fragments etc available) | Description |
| Ab02012-1.159 | Anti-Spike protein (RBD) [Clone Sb#14 - [Sb#68] |
| Ab02018-1.1 | Anti-Spike Protein [Clone CV1] |
| Ab02019-1.1 | Anti-Spike Protein (RBD) [Clone CV30] |
Agrisera
Agrisera offers various antibodies specific to cytokines and other signaling proteins related to coronavirus research.
| Item number | Description | Size |
| AS10 1571 | VEGFR1 | Vascular endothelial growth factor receptor 1 | 0.2 mg |
| AS10 1574 | VEGFR 3 | Vascular endothelial growth factor receptor 3 | 0.2 mg |
| AS10 1575 | VEGF | Vascular endothelial growth factor | 0.2 mg |
| AS10 1578 | VEGFR2 | Vascular endothelial growth factor receptor 2 | 0.2 mg |
| AS15 2869 | IFN alpha | Interferon alpha | 100 µg |
| AS20 4372 | S glycoprotein | SARS-CoV-2 Spike Glycoprotein (polyclonal) | 50 µg |
| AS20 4386 | S protein of Novel Coronavirus SARS-CoV-2/ 2019-nCoV (human) | 100 µl |
| AS20 4387 | Nucleoprotein (N) of Novel Coronavirus SARS-CoV-2/ 2019-nCoV (human) | 100 µl |
| AS20 4388-100 | Human Novel Coronavirus Nucleoprotein(N) | 100 µg |
| AS20 4388-1000 | Human Novel Coronavirus Nucleoprotein(N) | 1000 µg |
| AS20 4389-100 | Human Novel Coronavirus Spike glycoprotein(S) | 100 µg |
| AS20 4389-1000 | Human Novel Coronavirus Spike glycoprotein(S) | 1000 µg |
| AS20 4390 | Goat anti-Human IgG Fcy, HRP conjugated | 500 ul |
| IMS01-102-339 | TNFa | Tumor necrosis factor alpha | 100 µl |
| IMS01-127-320 | IL2 | Interleukin-2 | 100 µl (9.2 mg/ml) |
| IMS01-145-319 | IFNG | Interferon gamma | 100 µl (20 mg/ml) |
| IMS06-102-325 | TNFa | Tumor necrosis factor alpha, Biotin conjugated | 100 µl |
Asuragen
Asuragen, Inc., has developed an Armored RNA Quant® SARS-CoV-2 Control for use in developing assays in response to the COVID-19 pandemic.
| Item number | Description | Size |
| 52030 | Armored RNA Quant SARS-CoV-2 | 0,25 ml |
| 52031 | Armored RNA Quant RNAse P | 0,25 ml |
| 52036 | Armored RNA Quant SARS-CoV-2 Panel | 0,25 ml |
Click here for the news item.
Beijing Wantai
Our supplier and partner Beijing Wantai Biological Pharmacy has developed diverse serology and molecular kits for screening and confirmation of COVID-19. Time to results is critical and labs around the world are under a lot of pressure to provide test results fast. We can offer complete coronavirus diagnostic markers profile in just 75min.
The Dutch Ministry of Health has ordered one million tests together with blood bank Sanquin from Sanbio B.V. Read more.
The following kits are available:
| Item number | Description | Size |
| WS-1196 | SARS-CoV-2 IgM ELISA (CE-IVD), on stock | 96 T |
| WS-1096 | SARS-CoV-2 Ab ELISA (CE-IVD), on stock | 96 T |
| WJ-2750 | Rapid test for Corona virus Ab (CE-IVD), on stock | 50 T |
| WJ-2850 | SARS-CoV-2 Ag Rapid Test (FIA) (CE-IVD) | 50 T |
| WJ-2950 | SARS-CoV-2 Ag Rapid Test (Colloidal Gold) (CE-IVD) | 50 T |
| WS-1248 | Nucleic Acid Detection Kit 2019-nCoV (CE-IVD) | 48 T |
Read more about the difference between the rapid tests of Beijing Wantai.
SARS-CoV-2 Ag Rapid Test (FIA) (CE-IVD) of Beijing Wantai
Bio-Rad Antibodies
Bio-Rad Antibodies provides complete solutions for COVID-19 research.
- Antibodies for Immune Cell Characterization in COVID-19 Infection
- Antibodies to Immunoglobulins. To determine the development of an immune response against the SARS-CoV-2 virus, the detection of IgG, IgM, and IgA antibodies appears to be a sensitive approach.
- Rapid Custom Antibody Generation with HuCAL® Technology. Get highly specialized antibodies for coronavirus research, diagnostic testing, plus vaccine and therapeutic development.
Please contact us to help you selecting the right products for your COVID-19 research of Bio-Rad Antibodies.
Cayman Chemical
Cayman Chemical offers several products to study SARS-CoV-2-Host Interactions.
ACE2 Antibodies
ACE2 is a functional receptor that acts as an entry point into human lung cells for coronaviruses and plays a key role in both cross-species and human-to-human transmissions of the virus. Cayman offers the following ACE2 antibodies that are cross reactive to human tissues.
| Item number | Description | Host |
| 30582-100 | ACE2 (human) Monoclonal Antibody (Clone AC18F) | Mouse |
| 32028-100 | ACE2 (human) Monoclonal Antibody (Clone AC384; preservative free) | Mouse |
| 30583-50 | ACE2 (human) Monoclonal Antibody - Biotin (Clone AC18F) | Mouse |
| 30584-50 | ACE2 (human) Monoclonal Antibody (Clone AC384) | Mouse |
SARS-CoV-2 Spike and Nucleocapsid Proteins
SARS-CoV-2 viral proteins can be useful to understand the infectious strategies of the virus in order to identify possible treatment routes.
| Item number | Description | Size |
| 30430-1 | SARS-CoV-2 Surface Glycoprotein (433-506) | 1 mg |
| 30428-1 | SARS-CoV-2 Surface Glycoprotein Receptor Binding Motif | 1 mg |
| 30429-50 | SARS-CoV-2 Surface Glycoprotein Receptor Binding Domain | 50 ug |
| 30427-50 | SARS-CoV-2 Nucleocapsid Protein | 50 ug |
Please contact Sanbio for information about Detection Assays. All tools to study SARS-CoV-2-Host Interactions of Cayman Chemical can be found in this article.
Cusabio
Cusabio quickly developed and produced SARS-CoV-2 related products once the virus gene sequence information was obtained. Targets include the Spike protein (S), N protein (N) and ACE2. With a wide range of reagents, we have published a selection of items. For the full range, please contact Sanbio.
SARS-CoV-2 Protein Reagents:
| Item number | Description | Source |
| CSB-EP3325GMY | Recombinant Human Novel Coronavirus Nucleoprotein (N) | E.coli |
| CSB-YP3325GMY | Recombinant Human Novel Coronavirus Nucleoprotein (N) | Yeast |
| CSB-MP3325GMY | Recombinant Human Novel Coronavirus Nucleoprotein (N) | Mammalian cell |
| CSB-YP3325GMYa4 | Recombinant Human Novel Coronavirus Nucleoprotein (N) | Yeast |
| CSB-EP3325GMY1 | Recombinant Human Novel Coronavirus Nucleoprotein (N), partial | E.coli |
| CSB-EP3325GMY-B | Recombinant Human Novel Coronavirus Nucleoprotein (N), Biotinylated | E.coli |
| CSB-EP3398GND | Recombinant Severe acute respiratory syndrome coronavirus 2 Non-structural protein 3 (nsp3), partial | E.coli |
| CSB-EP3389GND | Recombinant Severe acute respiratory syndrome coronavirus 2 3C-like proteinase (NSP5) | E.coli |
| CSB-MP3388GND | Recombinant Severe acute respiratory syndrome coronavirus 2 Non-structural protein 9 (nsp9) | Mammalian cell |
| CSB-EP3388GND | Recombinant Severe acute respiratory syndrome coronavirus 2 Non-structural protein 9 (nsp9) | E.coli |
| CSB-MP3324GMY1 | Recombinant Human Novel Coronavirus Spike glycoprotein (S), partial | Mammalian cell |
| CSB-MP3324GMY1b1 | Recombinant Human Novel Coronavirus Spike glycoprotein (S), partial | Mammalian cell |
| CSB-YP3324GMY1 | Recombinant Human Novel Coronavirus Spike glycoprotein (S), partial | Yeast |
| CSB-MP3324GMY1(M1) | Recombinant Human Novel Coronavirus Spike glycoprotein (S) (V367F), partial | Mammalian cell |
| CSB-MP3324GMY1(M2) | Recombinant Human Novel Coronavirus Spike glycoprotein (S) (W436R), partial | Mammalian cell |
| CSB-MP3324GMY1(M4) | Recombinant Human Novel Coronavirus Spike glycoprotein (S) (G476S), partial | Mammalian cell |
| CSB-MP3324GMY1(M5) | Recombinant Human Novel Coronavirus Spike glycoprotein (S) (V483A), partial | Mammalian cell |
| CSB-MP3324GMY1-B | Recombinant Human Novel Coronavirus Spike glycoprotein (S), partial, Biotinylated | Mammalian cell |
| CSB-YP3324GMYa4 | Recombinant Human Novel Coronavirus Spike glycoprotein (S), partial | Yeast |
| CSB-MP3324GMY | Recombinant Human Novel Coronavirus Spike glycoprotein (S), partial | Mammalian cell |
| CSB-MP3324GMY(M1) | Recombinant Human Novel Coronavirus Spike glycoprotein (S) (D614G), partial | Mammalian cell |
Cytognos
Immune monitoring of COVID-19 patients allows us to study in depth their immune status which can provide prognostic value in terms of recovery dynamics. Therefore, clinical and therapeutic decisions based on this knowledge result in better and more personalized care for patients.
Read more in the COVID-19 whitepaper.
DNA Diagnostic
DNA Diagnostic has launched a simple, accurate and fast COVID-19 Antigen Detection Kit. Their Antigen detection kit gives the result within 15 minutes. Furthermore no specialist equipment or machinery is required. The test is CE/IVD-marked.
Read more about this product in the Product Sheet or IFU.
| Item number | Description |
| CV19FIC | New Coronavirus Antigen Detection Kit (SARS-CoV-2 N-Protein) |
Epigentek
EpiGentek has added a new antibody to their catalog for use in COVID-19 studies. The SARS-CoV-2 Furin Site Blocking Polyclonal Antibody is a unique antibody specific for targeting the furin cleavage site of SARS-CoV2 rather than directly inhibiting the enzymes. This antibody is suitable for SARS-CoV-2 Spike protein detection by ELISA and IP, SARS-CoV-2 furin site cleavage blockage, and SARS-CoV-2 spike protein neutralization.
| Item number | Description |
| A-1810-050 | SARS-CoV-2 Furin Site Blocking Polyclonal Antibody (50 ul) |
| A-1810-100 | SARS-CoV-2 Furin Site Blocking Polyclonal Antibody (100 ul) |
MBL International Corporation
MBL International can assist companies and academic investigators who are actively developing coronavirus vaccines with their unique QuickSwitch™ custom tetramer platform. QuickSwitch™ is a peptide screening plug and play platform that identifies peptides that are more likely to be immunogenic and yet generates corresponding Class I and Class II MHC tetramers. These platforms can identify and validate multi-epitope candidates of SARS-CoV-2 proteins that can potentially elicit for both CD4+ and CD8+ T-cell immune responses.
Reagent Kits for COVID-19 Detection
| Item number | Description | Product type |
| GS-S0201 | FLUOROSEARCH Novel Coronavirus (SARS-CoV-2) Detection Kit | Detection Kit |
| GS-S0201-2 | SARS-C0V-2 Positive Control | Positive Control |
| GS-J0201 | SMITEST EX-R&D | Extraction Kit |
Immune Detection Reagents for COVID-19 Research
| Item number | Class | Sequence | Target | Product type |
| SPC042 | Class I | ISDEFSSNV | ORF1ab polyprotein SARS-CoV-2 (5583-5591) | Peptide |
| SPC041 | Class I | VTQLYLGGM | ORF1ab polyprotein SARS-CoV-2 (5385-5393) | Peptide |
| SPC040 | Class I | KLPDDFTGCV | Chain A, SARS-CoV-2 spike glycoprotein (424-433) | Peptide |
| SPC039 | Class I | SIIAYTMSL | Chain A, SARS-CoV-2 spike glycoprotein (691-699) | Peptide |
| SPC038 | Class I | VVFLHVTYV | Chain A, SARS-CoV-2 spike glycoprotein (1060-1068) | Peptide |
| SPC037 | Class I | GNYNYLYRL | Chain A, SARS-CoV-2 spike glycoprotein (447-455) | Peptide |
| SPC036 | Class I | SIVRFPNI | Chain A, SARS-CoV-2 spike glycoprotein (325-332) | Peptide |
| SPC035 | Class I | VVLSFELL | Chain A, SARS-CoV-2 spike glycoprotein (511-518) | Peptide |
| SPC034 | Class I | INITRFQTL | Chain A, SARS-CoV-2 spike glycoprotein (233-241) | Peptide |
| SPC033 | Class I | MAYRFNGI | Chain A, SARS-CoV-2 spike glycoprotein (902-909) | Peptide |
| SPC032 | Class I | VNFNFNGL | Chain A, SARS-CoV-2 spike glycoprotein (539-546) | Peptide |
| SPC031 | Class I | NYLKRRVVF | SARS-CoV-2 ORF1ab (3159-3167) | Peptide |
| SPC030 | Class I | FYGGWHNML | SARS-C0V-2 ORF1ab (4986-4994) | Peptide |
| SPC029 | Class I | DYVYNPFMI | SARS-CoV-2 ORF1ab (6159-6167) | Peptide |
| SPC028 | Class I | TTIKPVTYK | SARS-CoV-2 ORF1ab (1875-1883) | Peptide |
| SPC027 | Class I | STFNVPMEK | SARS-CoV-2 ORF1ab (2600-2608) | Peptide |
| SPC026 | Class I | KTFPPTEPK | SARS-CoV-2 nucleocapsid phosphoprotein (362-370) | Peptide |
| SPC025 | Class I | KSAGFPFNK | SARS-CoV-2 ORF1ab (4892-4900) | Peptide |
| SPC024 | Class I | ASMPTTIAK | SARS-CoV-2 ORF1ab (2192-2200) | Peptide |
| SPC023 | Class I | YLYALVYFL | SARS-CoV-2 ORF3a protein (107-115) | Peptide |
| SPC022 | Class I | YLNTLTLAV | SARS-CoV-2 ORF1ab (6851-6859) | Peptide |
| SPC021 | Class I | YLDAYNMMI | SARS-CoV-2 ORF1ab (6419-6427) | Peptide |
| SPC020 | Class I | TLMNVLTLV | SARS-CoV-2 ORF1ab (3710-3718) | Peptide |
| SPC019 | Class I | SMWALIISV | SARS-CoV-2 ORF1ab (3732-3740) | Peptide |
| SPC018 | Class I | LLYDANYFL | SARS-CoV-2 ORF3a protein (139-147) | Peptide |
| SPC017 | Class I | LLLDDFVEII | SARS-CoV-2 ORF1ab (6749-6758) | Peptide |
| SPC016 | Class I | FLLNKEMYL | SARS-CoV-2 ORF1ab (3183-3191) | Peptide |
| SPC015 | Class I | FLAHIQWMV | SARS-CoV-2 ORF1ab (3122-3130) | Peptide |
| SPC014 | Class II | YFTSDYYQLYSTQLS | SARS-CoV-2 ORF3a protein (206-220) | Peptide |
| SPC013 | Class II | WPQIAQFAPSASAFF | SARS-CoV-2 nucleocapsid phosphoprotein (301-315) | Peptide |
| SPC012 | Class II | TRFQTLLALHRSYLT | SARS-CoV-2 chain A spike glycoprotein (236-250) | Peptide |
| SPC011 | Class II | SEFSSLPSYAAFATA | SARS-CoV-2 ORF1ab polyprotein (3946-3960) | Peptide |
| SPC010 | Class II | RAMPNMLRIMASLVL | SARS-CoV-2 ORF1ab polyprotein (5016-5030) | Peptide |
| SPC009 | Class II | MWLSYFIASFRLFAR | SARS-CoV-2 membrane glycoprotein (91-105) | Peptide |
| SPC008 | Class II | MDLFMRIFTIGTVTL | SARS-CoV-2 ORF3a protein (1-15) | Peptide |
| SPC007 | Class II | LSYYKLGASQRVAGD | SARS-CoV-2 membrane glycoprotein (176-190) | Peptide |
| SPC006 | Class II | LLLLDRLNQLESKMS | SARS-CoV-2 nucleocapsid phosphoprotein (221-235) | Peptide |
| SPC005 | Class II | LEASFNYLKSPNFSK | SARS-CoV-2 ORF1ab polyprotein (2211-2225) | Peptide |
| SPC004 | Class II | FYVYSRVKNLNSSRV | SARS-CoV-2 envelope protein (56-70) | Peptide |
| SPC003 | Class II | ESPFVMMSAPPAQYE | SARS-CoV-2 ORF1ab polyprotein (1801-1815) | Peptide |
| SPC002 | Class II | EEIAIILASFSASTS | SARS-CoV-2 ORF1ab polyprotein (471-485) | Peptide |
| SPC001 | Class II | EAFEKMVSLLSVLLS | SARS-CoV-2 ORF1ab polyprotein (3906-3920) | Peptide |
MHC Tetramers for COVID-19 Cell Detection
| Item number | Class | Sequence | Target |
| TB-0174-1 | Class I | RLNEVAKNL | HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer |
| TB-0174-2 | Class I | RLNEVAKNL | HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer |
| TB-0174-4 | Class I | RLNEVAKNL | HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer |
| TB-0174-M | Class I | RLNEVAKNL | Biotinylated HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Monomer |
| TB-0174-M2 | Class I | RLNEVAKNL | Biotinylated HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Monomer |
| TB-0175-1 | Class I | KLPDDFTGCV | HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer |
| TB-0175-2 | Class I | KLPDDFTGCV | HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer |
| TB-0175-4 | Class I | KLPDDFTGCV | HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer |
| TB-0175-M | Class I | KLPDDFTGCV | Biotinylated HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Monomer |
| TB-0175-M2 | Class I | KLPDDFTGCV | Biotinylated HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Monomer |
| TB-0176-1 | Class I | YLQPRTFLL | HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer |
| TB-0176-2 | Class I | YLQPRTFLL | HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer |
| TB-0176-4 | Class I | YLQPRTFLL | HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer |
| TB-0176-M | Class I | YLQPRTFLL | Biotinylated HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Monomer |
| TB-0176-M2 | Class I | YLQPRTFLL | Biotinylated HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Monomer |
| TB-0177-1 | Class I | RLQSLQTYV | HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer |
| TB-0177-2 | Class I | RLQSLQTYV | HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer |
| TB-0177-4 | Class I | RLQSLQTYV | HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Tetramer |
| TB-0177-M | Class I | RLQSLQTYV | Biotinylated HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Monomer |
| TB-0177-M2 | Class I | RLQSLQTYV | Biotinylated HLA-A*02:01 SARS-CoV-2 Spike Glycoprotein Monomer |
Norgen Biotek
Norgen Biotek offers two COVID-19 complete workflow solutions. For diagnostic use and for research use.
In vitro diagnostic workflow (all products are CE-IVD).
| Use | Item number | Description | Available sizes |
| 1. Sample Collection & Preservation | NGDx69200 | Total Nucleic Acid Preservation Tubes Dx | 50 units |
| NG53800 | Saliva RNA Collection and Preservation Devices Dx | 50 devices | |
| 2. RNA Isolation | NGDx69100 | Saliva / Swab RNA Purification Kit Dx | 50 preps |
| NGDx69300 | Saliva / Swab RNA Purification 96-Well Kit Dx | 2 x 96-well plates | |
| NGDx17200 | Total RNA Purification Kit Dx | 50 preps | |
| 3. PCR based detection | NGDxTM67200 | COVID-19 TaqMan RT-PCR Kit (E/RdRP genes) Dx | 500 reactions |
| NGDxTM67100 | 2019-nCoV TaqMan RT-PCR Kit Dx | 50 reactions, 500 reactions |
Workflow for research use only. Not for in vitro diagnostic use.
| Use | Item number | Description | Available sizes |
| 1. Sample Collection & Preservation | NG69200 | Total Nucleic Acid Preservation Tubes | 50 tubes |
| NGRU53800 | Saliva RNA Collection and Preservation Device | 50 Devices | |
| 2. RNA Isolation | NG69100 | Saliva/Swab RNA Purification Kit | 50 Preps |
| NG69300 | Saliva/Swab RNA Purification 96-Well Kit | 2 x 96-well plates | |
| NG17200 NG37500 NG17250 NG17270 |
Total RNA Purification Kit | 50 Preps 100 Preps 250 preps 500 preps |
|
| NG24300 NG24350 |
Total RNA Purification 96-Well Kit | 2 x 96-well plates | |
| 3. PCR based detection | TM67200 | COVID-19 TaqMan RT-PCR Kit (E/RdRP genes) | 500 reactions |
| TM67100 TM67120 |
2019-nCoV TaqMan RT-PCR Kit | 50 reactions, 500 reactions | |
| 4. Components and add-ons | TM67101 TM67130 |
2019-nCoV Primer & Probe Mixes | 50 reactions, 500 reactions |
| PC67102 PC67120 |
2019-nCoV RT-PCR Positive Control | 50 reactions, 500 reactions (per tube) | |
| NG28113 NG28115 |
2X One-Step RT-PCR Master Mix | 100 reactions, 500 reactions |
OriGene Technologies Inc
OriGene supports COVID-19 research with:
- Products to detect the presence of the virus
- Products to detect the presence of antibodies
- Products for the purpose of Virus-Host interaction
The best sellers of Origene:
| Item number | Description | Size |
| TP701119 | SARS-CoV-2 Spike-Membrane Recombinant Fusion Protein (Bioactivity Verified) | 50 ug |
| TA890226 | SARS-CoV-2 N Protein Rabbit Polyclonal Antibody | 100 ul |
| RC208442L2V | ACE2 Lentiviral Particle | 200 ul |
| TA803841 | (ACE2) Mouse Monoclonal Antibody [Clone ID: OTI4D2] | 0,1 ml |
Proteintech
Proteintech has a variety of antibodies, ELISA kits and proteins to help understand and accelerate infectious disease research, including SARS-COV-2.
Hoffman and colleagues recently in Cell (PMID: 32142651) detailed how the novel coronavirus uses ACE2 and TMPRSS2 to gain access to the cell and replicate. Proteintech offers antibodies for both ACE2 and TMPRSS2 to accelerate your research on SARS-COV-2 and other viruses.
| Item number | Description | Size |
| 21115-1-AP | ACE2 Antibody, Rabbit, Polyclonal | 150 ul |
| 66699-1-Ig-S | ACE2 Antibody, Mouse, Monoclonal | 20 ul |
| 14437-1-AP | TMPRSS2 Antibody, Rabbit, Polyclonal | 150 ul |
Please contact us to receive a digital copy of the complete coronavirus & viral infection catalogue of Proteintech.
ScienCell
ScienCell's SARS-CoV-2 Products
Viral RNA Isolation Kit
ScienCell’s Viral RNA Isolation Kit provides a fast and reliable way to purify viral RNA from a variety of samples.
| Item number | Description | Size |
| SCCMB891 | Viral RNA Isolation Kit | 100 preps |
SARS-CoV-2 Coronavirus Real-time RT-PCR Detection Kit
FDA ranks ScienCell SARS-CoV-2 detection kit #2 in sensitivity among all kits in the US.
This detection Kit is a real-time RT-PCR test intended for the qualitative detection of nucleic acids from the SARS-CoV-2 in nasal, nasopharyngeal, oropharyngeal swab specimens, and bronchoalveolar lavage from individuals suspected of COVID-19 by their healthcare provider.
| Item number | Description | Size |
| SCCRX7038 | SARS-CoV-2 Coronavirus Real-time RT-PCR Detection Kit | 100 specimens |
SARS-CoV-2 Multiplex RT-qPCR Detection Kit
This detection Kit (SCVMPD) is designed to detect the presence of SARS-CoV-2 Coronavirus in respiratory specimens and serum samples using FAM/HEX multiplex primer/probe sets. One-step TaqProbe RT-qPCR master mix and all required controls are conveniently included in the kit.
| Item number | Description | Size |
| SCCRU7048 | SARS-CoV-2 Multiplex RT-qPCR Detection Kit | 100 specimens |
SARS-CoV-2 SYBR® Green RT-qPCR Quantification Kit
ScienCell's SARS-CoV-2 SYBR® Green RT-qPCR Quantification Kit (SVSGQ) is designed to quantify the SARS-CoV-2 coronavirus presence in samples.
| Item number | Description | Size |
| SCCRU7058 | SARS-CoV-2 SYBR® Green RT-qPCR Quantification Kit | 100 specimens |
SignalChem BioTech
Since the outbreak, SignalChem has already established expression systems for production of SARS-CoV-2 Spike proteins, RBD fragments, N protein, and other related protein products on a large scale to help detect IgG / IgM in potential patients. For more information view below video or visit the product webpage of SignalChem.
System Biosciences (SBI)
Get SARS-CoV-2 studies up and running quickly and efficiently with SBI's new and growing family of COVID-19 research tools.
All based on their robust pCDH lentivector technology, they have a ready-to-use HEK293 ACE2 Stable Cell Line as well as a range of SARS-CoV-2-related expression lentivectors that are available as both plasmid and pre-packaged lentivirus.
| Item number | Description | Size |
| CVD19-200A-1 | HEK293 ACE2 Stable Cell Line | 2 x 10^6 Cells |
| CVD19-100PA-1 | ACE2 Expression Lentivector, pCDH-CMV-ACE2-EF1α-Puro (Plasmid) | 10 µg |
| CVD19-100VA-1 | ACE2 Expression Lentivector, pCDH-CMV-ACE2-EF1-Puro (Pre-packaged Lentivirus) | >2 x 10^6 IFUs |
| CVD19-120PA-1 | SARS-CoV-2 Nucleocapsid (N protein) Expression Lentivector, pCDH-CMV-SARS-CoV-2-N-EF1α-Puro (Plasmid) | 10 µg |
| CVD19-120VA-1 | SARS-CoV-2 Nucleocapsid (N protein) Expression Lentivector, pCDH-CMV-SARS-CoV-2-N-EF1α-Puro (Pre-packaged Lentivirus) | >2 x 10^6 IFUs |
| CVD19-130PA-1 | SARS-CoV-2 Spike Glycoprotein (S) Expression Lentivector, pCDH-CMV-SARS-CoV-2-S-EF1α-Puro (Plasmid) | 10 µg |
| CVD19-130VA-1 | SARS-CoV-2 Spike Glycoprotein (S) Expression Lentivector, pCDH-CMV-SARS-CoV-2-S-EF1α-Puro (Pre-packaged Lentivirus) | >2 x 10^6 IFUs |
| CVD19-135PA-1 | SARS-CoV-2 Humanized Spike Glycoprotein (S) Expression Lentivector, pCDH-CMV-SARS-CoV-2-hS-EF1α-Puro (Plasmid) | 10 µg |
| CVD19-135VA-1 | SARS-CoV-2 Spike Glycoprotein (S) Expression Lentivector, pCDH-CMV-SARS-CoV-2-hS-EF1α-Puro (Pre-packaged Lentivirus) | >2 x 10^6 IFUs |
NEW!
A modified version of SBI's pPACK-SPIKE kit: the new pPACK-SPIKE D614G, SARS-CoV-2 “S” Pseudotype – D614G Mutant – Lentivector Packaging Mix. This is an expansion of their recently released pPACK-SPIKE technology, which can be used to produce SARS-CoV-2 “S” pseudotyped lentiviral particles. In this case, SBI modified the coding sequence for the “Spike” envelope protein to have the D614G mutation. This mutation has been characterized as having increasing prevalence around the world, with preliminary papers showing this mutant Spike enabling higher infectivity, at least in the lab. Researchers can study SARS-CoV-2 D614G Spike protein mutant with this system for generating high titers of D614G Spike protein pseudotyped lentivirus particles. Additional features and benefits include:
- Based on SBI’s popular and highly cited pPACKH1 Packaging System
- Uses codon-optimized SARS-CoV-2 D614G “S” protein in place of VSV-G envelope protein
- Ideal for COVID-19 research, such as neutralization assays, under BSL2 conditions
- Package any 3rd-generation lentivector reporter of your choice, including SBI’s popular Lenti-Labeler reporters
- Use with pPACK-BALD™, an envelope protein-free lentivector packaging system that is an ideal negative control
- Compare to the Spike protein from the original Wuhan-Hu-1 strain when you use pPACK-SPIKE
| Item number | Description | Size |
| CVD19-530A-1 | pPACK-SPIKE D614G, SARS-CoV-2 “S” Pseudotype – D614G Mutant – Lentivector Packaging Mix | 10 rxn |
| CVD19-540A-1 | pPACK-SPIKE D614G, SARS-CoV-2 “S” Pseudotype – D614G Mutant – Lentivector Packaging Mix (XL) | 25 rxn |
| CVD19-550A-KIT | pPACK-SPIKE Combo Kit, includes Cat# CVD19-530A-1, plus PureFection Transfection Reagent and PEG-it Virus Concentration solution | 1 kit |